Equities

Applied DNA Sciences Inc

Applied DNA Sciences Inc

Actions
IndustrialsElectronic and Electrical Equipment
  • Price (USD)1.25
  • Today's Change0.035 / 2.89%
  • Shares traded645.68k
  • 1 Year change-95.10%
  • Beta0.3709
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 19-Sep-24
Select bar for recommendation details.
Recommendations19-Sep-24
Buy0
Outperform0
Hold1
Sell0
Strong Sell0

Share price forecast in USD

The one analyst offering a 12 month price target expects Applied DNA Sciences Inc share price to rise to 1.50 in the next year from the last price of 1.25.
High20.5%1.50
Med20.5%1.50
Low20.5%1.50

Earnings history & estimates in USD

On Aug 08, 2024, Applied DNA Sciences Inc reported 3rd quarter 2024 earnings of 0.47 per share. This result exceeded the -0.35 consensus loss of the one analyst covering the company and outperformed last year's 3rd quarter results by 5.27.
The next earnings announcement is expected on Dec 05, 2024.
Average growth rate-45.98%
Applied DNA Sciences Inc reported annual 2023 losses of -15.20 per share on Dec 07, 2023.
Average growth rate+44.82%
More ▼

Revenue history & estimates in USD

Applied DNA Sciences, Inc. had 3rd quarter 2024 revenues of 797.00k. This missed the 1.08m consensus estimate of the 2 analysts following the company. This was 84.86% below the prior year's 3rd quarter results.
Average growth rate-17.24%
Applied DNA Sciences, Inc. had revenues for the full year 2023 of 13.37m. This was 26.43% below the prior year's results.
Average growth rate+94.55%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.